baber/WOPTO huggingface dataset:
Patent CA-1338454-E (CA)
Inventor: HOFFMAN PAUL
IPC: E04B1/00
Filed: 1995-01-20
Granted: 1996-07-16
Abstract: A body member comprising either a concrete block or molded or stamped product, includes upwardly opening recesses forming an anchor seat for building elements. The recesses may extend fully from side to side and also open out the sides so that building elements can be laid horizontally therein or fully across the body member. The recesses also include a central socket for receiving an upright pillar. Embodiments of the invention may include depending foot members. Embodiments of the invention also include structure for fastening building elements to the bodymember. A further embodiment employs depending projections at outer portions thereof which frictionally fit on top of a base block and stabilize the body member against lateral movement.
Patent PT-1196662-E (PT)
Title: Segmental retaining wall system
Inventor: BORGERSEN SVENN
IPC: E02D29/02
Filed: 2000-01-27
Abstract: A modular earth retaining wall system comprising a plurality of similarly configured wall blocks that have lock channels and lock flanges that provide a locking mechanism for resisting leaning or toppling of the blocks. A positive retaining mechanism is also provided for attaching reinforcement fabrics to the retaining wall in between mating courses of wall blocks. This mechanism secures the reinforcement fabrics in place and permits the fabrics to extend along the entire contact area between adjacent stacked wall blocks to avoid an aggregate leaning effect. The retaining mechanism includes a retaining bar that is place don top of the reinforcement fabric within the lock channel. The retaining bar holds the fabric against a wall of the lock channel in response to tensile loads applied to the fabric to prevent it from being pulled out of the retaining wall.
Patent PT-1229994-E (PT)
Inventor: VERHAAK MICHAEL JOHANNES FRANC
IPC: B01D53/86
Filed: 2000-09-06
Abstract: A method for the selective catalyst reduction of nitrous oxide (N2O) in the presence of a solid catalyst, with the addition of a saturated hydrocarbon as reducing agent. The catalyst used is a promoted, iron-containing zeolite. As a result, it is possible to increase the conversion of (N2O) compared to unpromoted iron-containing zeolite catalysts. The promoted catalyst is active at temperatures below 350° C. Furthermore, it has been found that the iron-containing zeolite catalysts which are promoted with precious metal also give low emissions of CO and residual hydrocarbons. The catalyst is also very active under high process pressures and in the presence of sulphur.
Patent PT-1177776-E (PT)
Inventor: GARCIA EMILIO MARTINEZ
IPC: A61D19/02
Filed: 2000-11-03
Abstract: It comprises a tube or catheter (1) that is introduced into the animal's vagina up to the cervix duct (19); characterized in that it additionally comprises a flexible probe (6) constituted of a first flexible tubular body (12), and the outside of which is covered by a layer of a flexible material; all to allow that the probe, after reaching the distal end of the tube (1), may progress through the cervix duct (19) and thereafter through the cervix horn (22). This structure allows to introduce a fluid with spermatozoids, embryos or therapeutic solutions to the anterior third of the uterus horn, or to obtain embryos from the anterior portions of the uterus horn, and all this without sedation or anesthesia and without disturbing the animal's well-being. To facilitate obtaining embryos, the probe includes an elastic small external coating (28) that is inflated through a flexible tube (27) for adapting itself to the uterus horn (22) preventing refluxes when carrying out absorption. It is essentially applied to porcine livestock, small ruminants and any other animal species. <IMAGE>
Patent PT-1255465-E (PT)
Inventor: FAVAGROSSA FRANCESCO
IPC: A46D3/04
Filed: 2000-11-30
Abstract: The present invention relates to a brush which has been specifically designed for automatic motor vehicle washing systems, which comprises a bristle supporting layer (1) which can be wound about a shaft. The main feature of the invention is that the bristles (2) are made by extruding a closed cell foamed plastics material.
Patent PT-1261820-E (PT)
Title: Labyrinth seal between rotating parts
Inventor: HALLMANN DIETER
IPC: F16J15/447
Filed: 2001-02-26
Abstract: The labyrinth seal is made up of two sections (7, 8), the outer section having annular components (9) which form conical seal gaps (12) with the surface (13) of the other component.
Patent PT-1358481-E (PT)
Inventor: POMPIDOU ALAIN
IPC: A61B5/00
Filed: 2001-03-16
Abstract: This invention concerns an apparatus for chemical or biological analysis or treatment in situ comprising (i) a microsystem for investigation of a substrate and/or for delivery of active agents in a substrate and (ii) a flexible rod to one end of which the microsystem is attached and the other end of which is intended for the control of said microsystem. The microsystem is advantageously of the type comprising a support on the surface of which predefined regions are arrayed, each containing different chemical or biological substances for investigation or treatment of the substrate where the microsystem is brought in contact thanks to the flexible rod.
Patent PT-1274374-E (PT)
Title: Disposable articulated spacing device for surgical treatment of joints of the human body
Inventor: FACCIOLI GIOVANNI
IPC: A61B17/56
Filed: 2001-04-09
Abstract: A disposable articulated spacing device for the treatment of joints of the human body, particularly for temporary replacing an explanted joint prosthesis, comprises at least one first member (2) able to be secured to a first articulation end and at least one second member (3) able to be secured to the other articulation end, both said members (2, 3) being pre-formed and made entirely of biological compatible and porous material suitable to be added with pharmaceutical and therapeutical products; the pre-formed members (2, 3) are reciprocally coupled in an articulated manner to maintain a suitable joint space and at least a partial articulation for the time necessary to perform the further implantation of a joint prosthesis. The biologically compatible and porous material is chosen among metals, metallic alloys, organo-metals, ceramics, glasses, plastics materials, bone cements and combinations thereof. The articulated spacing device maintains a suitable space in the joint seat while allowing a considerable articulated mobility, and re-establishes suitable conditions of implantation of a new permanent joint prosthesis.
Patent PT-1280578-E (PT)
Title: Integral balloon tracheostomy tube
Inventor: FAUZA DARIO O
IPC: A61B17/24
Filed: 2001-04-27
Abstract: The present invention relates to a tracheostomy device with an inflatable balloon (1) attached to a hollow tube (2) by means of two areas of adhesion (1a and 1b) whose ortogonal projections are not contiguous or, in other words, are at an angle (alpha) other than 180°. This balloon (1) communicates with the environment by means of a capped, valved flexible conduit (4). A movable flange (3) allows for extra fixation of the device around a patient's neck. A displaceable inner tube (5) can be removed in case of severe acute obstruction, allowing for immediate establishment of air flow. The design and distribution of the components of this tracheostomy device contribute to increased safety and comfort of tracheostomies by: enhancing the its anchorability, hence better stabilizing it within the trachea; improving its placement within the airway; increasing the volume, hence lowering the pressure inside its balloon (1); enhancing the balloon's (1) volume-to-pressure curve; completely sealing the trachea from the tracheostomy wound, larynx and pharynx; shortening the tube (2) size and providing a movable neck flange (3).
Patent PT-1324981-E (PT)
Title: Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors
Inventor: PAN WENXI
IPC: A61L31/00
Filed: 2001-10-05
Abstract: Phenyl acetamide compounds are described, including compounds of or a solvate, hydrate or pharmaceutically acceptable salt thereof; wherein R<SUP>3</SUP>-R<SUP>6</SUP>, R<SUP>11</SUP>, B, Y and W are set forth in the specification. The compounds of the invention are potent inhibitors of proteases, especially trypsin-like serine proteases, such as thrombin and factor Xa. Compositions for inhibiting loss of blood platelets, inhibiting formation of blood platelet aggregates, inhibiting formation of fibrin, inhibiting thrombus formation, and inhibiting embolus formation are described. Other uses of compounds of the invention are as anticoagulants either embedded in or physically linked to materials used in the manufacture of devices used in blood collection, blood circulation, and blood storage, such as catheters, blood dialysis machines, blood collection syringes and tubes, blood lines and stents. Additionally, the compounds can be detectably labeled and employed for in vivo imaging of thrombi.
Patent PT-1366781-E (PT)
Title: Apparatus for treating a body part using an electromagnetic field
Inventor: RICHARD MARKOLL DR
IPC: A61N2/02
Filed: 2002-05-29
Abstract: An apparatus for treating a body part comprises a cylindrical coil (1) for generating an electromagnetic field of under 20 Gauss, the cylindrical coil (1) being arranged so as to accommodate the body part and to subject said body part to said electromagnetic field, means for driving the coil (1) by a pulsed DC voltage having a rectangular wave form consisting of abruptly rising and abruptly deteriorating current pulsing at the rate of 1 to 30 pulse bursts per second, and supporting structure (4) configured to support said body part inside said cylindrical coil (1). Said supporting structure (4) comprises a rigid receiving surface (5) extending through the coil substantially in parallel to the center axis thereof and being arranged so as to support the body part in a position which is displaced, from the center of the cylindrical coil (1), in the direction of the inner periphery of the cylindrical coil (1). <IMAGE> <IMAGE> <IMAGE>
Patent PT-1366365-E (PT)
Title: Detection of microorganisms in liquid hydrocarbon fuel
Inventor: KELLEY JOAN
IPC: G01N33/22
Filed: 2002-02-21
Abstract: A method of analysis of a hydrocarbon fuel for the presence of a micro-organism comprises contacting a fuel sample with an aqueous diluent and with an antibody reactive with the micro-organism, or reactive with a metabolite or breakdown product produced by the micro-organism, to detect the presence or absence of the micro-organism.
Patent PT-1534483-E (PT)
Inventor: MARCELLO TONCELLI
IPC: C04B35/63
Filed: 2002-09-04
Abstract: In the manufacture of slabs and panels of ceramic material according to the vacuum vibrocompaction method described in Italian patent 1,311,858, the initial mix is formed using ceramic sands having a grain size of less than 2.5 mm, preferably less than 1 mm, and ceramic powders, together with a binding additive in the form of an aqueous solution consisting of sodium silicate in a concentration greater than 24 DEG Baumé, fibres of high-melting transparent inorganic material, preferably high-melting glass, also being added to the mix. The slabs obtained have an improved mechanical strength, a reduced porosity and improved aesthetic properties, in addition to being free from cracks and microscopic fissures.
Patent PT-1455600-E (PT)
Title: Food or pet food composition containing plant extract from amelanchier for bone health
Inventor: OFFORD-CAVIN ELIZABETH
IPC: A23K1/16
Filed: 2002-12-10
Abstract: The present invention relates to a composition for maintenance of bone health or prevention, alleviation and/or treatment of bone disorders. It also relates to the use of the composition in the manufacture of a nutritional product, a supplement or a medicament; and a method of promoting bone growth or for the maintenance of bone health which comprises administering an effective amount of the composition.
Patent PT-1566173-E (PT)
Title: Pharmaceutical composition for oral application and method for preparing thereof
Inventor: MATTERN CLAUDIA
IPC: A61K9/20
Filed: 2004-02-20
Abstract: The present invention relates to a pharmaceutical composition for oral application comprising: i) an anthelmintic agent; ii) a first excipient having a porous structure with an inner surface of about 500 to 1500 m<2>/g and a surface area according to BET of up to about 5000 m<2>/g; as well as to a method of preparing such a composition. <IMAGE>
Patent PT-1470815-E (PT)
Inventor: SACKLER RICHARD
IPC: A61K9/54
Filed: 1994-11-22
Abstract: Oral sustained release opioid formulation comprises: an opioid analgesic, a retardant material to cause the opioid analgesic to be released at a rate to provide an analgesic effect after oral admin. to a human patient for 24 hrs, the formulation when administered in humans providing an initially rapid rate of rise in the plasma conc. of the opioid characterised by providing an absorption half-life of 1-8 hrs. in the fastened state. Method for titrating human patients with a sustained release oral opioid formulation comprises: 1) administering to a human patient on a once-a-day basis a unit dose of an oral sustained release formulation comprising a dose of an opioid analgesic and a retardant material as described above, 2) monitoring pharmacokinetic and pharmacodynamic parameters elicited by the formulation in the human patient and determining whether the pharmacokinetic and/or pharmacodynamic  parameters are appropriate to treat the patient on a repeated basis, 3) titrating t he patient by adjusting the dose of the opioid analgesic administered to the patient by administering a unit dose of the sustained release opioid analgesic formulation if it is determined that the pharmacokinetic and/or the pharmacodynamic parameters are not satisfactory or maintaining the dose of the opioid analgesic in the unit dose at a previously administered amt. if the pharmacokinetic and/or pharmacodynamic parameters are deemed appropriate, 4) continuing the step 3 titration by adjusting the dose of the opioid analgesic until appropriate steady state pharmacokinetic and/or pharmacodynamic parameters are achieved in the patient, and 5) continuing the admin. of the dose of the opioid analgesic in the oral sustained release formulation on a once-a-day basis until treatment is terminated.
Patent PT-1571016-E (PT)
Title: Stroke stop device of the suspensions of a vehicle
Inventor: MARCACCI MAURIZIO
IPC: B62K5/01
Filed: 2005-02-01
Abstract: Stroke stop device (1) for the suspensions of a vehicle of the type provided with at least one shock absorber (2) equipped with a first (3) and second (4) portion that can slide relatively. The device also comprises a pin element (44) integral with the first portion (3) of the shock absorber (2) and able to slide with respect to a caliper element (45) integral with the second portion (4) of the shock absorber (2). The caliper element (45) can be actuated closed to lock the sliding of the pin element (44) and to stop the stroke of the shock absorber (2). <IMAGE>
Patent PT-1720966-E (PT)
Title: Nanoelectronic and microelectronic cleaning compositions
Inventor: HSU CHIEN-PIN SHERMAN
IPC: C11D3/39
Filed: 2005-02-11
Abstract: Nanoelectronic and microelectronic cleaning corn positions for cleaning nanoelectronic and microelectronic substrates under supercritical fluid state conditions, and particularly cleaning compositions useful with and having improved compatibility with nanoelectronic and microelectronic substrates characterized by silicon dioxide, sensitive low-n or high-K dielectrics and copper, tungsten, tantalum, nickel, gold, cobalt, palladium, platinum, chromium, ruthenium, rhodium, iridium, hafnium, titanium, molybdenum, tin and other metallization, as well as substrates of A1 or Al(Cu) metallizations and advanced interconnect technologies, are provided by nanoelectronic and microelectronic cleaning compositions.
Patent PT-1857451-E (PT)
Title: A process for the preparation of an intermediate useful for the asymmetric synthesis of (+)duloxetine
Inventor: POGGIALI ANDREA
IPC: C07D333/20
Filed: 2006-05-05
Abstract: A process for the preparation of (+)duloxetine, or an acid addition salt thereof, comprising: 
(i) Resolving racemic (±)N-methyl duloxetine with a less than stoichiometric amount of a chiral acid in combination with suitable amounts of a hydrohalogen acid to give a salt of the chiral acid and (+)N-methyl duloxetine, substantially free from (-)N-methyl duloxetine; 
(ii) Demethylating the (+)N-methyl duloxetine prepared in step (i) to give (+)duloxetine or another acid addition salt in enantiomerically pure form.
Patent PT-1685839-E (PT)
Title: Pharmaceutical oral dosage form comprising a combination of an opioid agonist and opioid antagonist
Inventor: KAIKO ROBERT F
IPC: A61K45/06
Filed: 1998-12-22
Abstract: The invention relates to oral dosage forms comprising a combination of an orally analgesically effective amount of an opioid agonist and an orally active opioid antagonist, the opioid antagonist being included in a ratio to the opioid agonist to provide a combination product which is analgesically effective when the combination is administered orally, but which is aversive in a physically dependent subject when administered at the same dose or at a higher dose than the usually prescribed dose of opioid agonist.
Patent PT-1881887-E (PT)
Title: Granulating device
Inventor: SCHULZ HELMUTH
IPC: B01J2/20
Filed: 2006-05-16
Abstract: The invention relates to a device for granulation of an ejected material from at least one nozzle (7), in particular a thermoplastic plastic, with a perforated plate (2) comprising the nozzles (7). A blade head (10) supporting several blades (11) lies opposite the same, fixed to a shaft (9) which is rotatably driven by a motor (13). The motor (13) is suspended such as to be displaced relative to the housing (1) by means of a suspension (15), however the above is suspended in such a manner that displacement is only possible in the direction of the axis (8) of the shaft (9) and not in a radial direction. The suspension (15) comprises at least one membrane (14) which suspends the motor (13) on the granulator housing (1). The motor (13) can be adjusted relative to the perforated plate (2) by means of an adjuster device (27), such that the desired pressure of the blade on the perforated plate (2) is maintained. The excised granulate particles are drawn out of the housing (1) by means of coolant.
Patent PT-1922334-E (PT)
Title: Tumor-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules and related anti-cancer vaccine
Inventor: SINGH HARPREET
IPC: A61K38/00
Filed: 2006-09-05
Abstract: The present invention relates to immunotherapeutic methods, and molecules and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumour-associated T-helper cell peptide epitopes, alone or in combination with other tumour-associated peptides, that serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumour immune responses. In particular, the present invention relates to two novel peptide sequences derived from HLA class II molecules of human tumour cell lines which can be used in vaccine compositions for eliciting anti-tumour immune responses.
Patent PT-1863042-E (PT)
Title: A control device for driving ac solenoids and dc bistable solenoids, specifically for electrovalves of irrigation systems.
Inventor: BRUNDISINI ANDREA
IPC: A01G25/00
Filed: 2007-05-25
Abstract: There is described a control device (1) that allows to drive both AC solenoids and DC bistable solenoids. The control device (1) comprises power supply terminals (2, 3; 11, 12, 17) which may selectively be connected to an AC or DC voltage source, load terminals (4, 5) which may be connected to a driven solenoid (L), at least one triac device (T) connected in series to said driven solenoid (L), means (G) which may be controlled to switch on said triac (T). There are further provided selector means (S) interposed between said power supply terminals (2, 3; 11, 12, 17) and said load terminals (4, 5) to switch the control device (1) between a first configuration suitable for the power supply of an AC solenoid (L) and a second configuration suitable for the power supply of a DC bistable solenoid (L) and inverter means (A) which may be controlled to invert the voltage polarity at the load terminals (4, 5) with respect to that applied at the power supply terminals (2, 3; 11, 12, 17) when the control device (1) is selected in said second configuration (Fig. 1)
Patent PT-2040812-E (PT)
Title: A method and device for purifying wastewater
Inventor: GUSTAFSSON BERT
IPC: C02F9/00
Filed: 2007-07-13
Abstract: Wastewater can be purified in a device, which includes a cup-shaped vessel, having a wastewater inlet tube for the water at a certain level and an outlet tube at a lower level than the inlet tube, and a horizontal distribution disc, which vertically divides the vessel, has at least one opening and is provided with a substantially vertical distribution tube for receiving the water from the inlet tube. Water above the distribution disc is pumped through a filter head with a filter. Filtered water is let out through the outlet tube, whereas unfiltered water is transferred back to the distribution tube. Flocculation agent is added to the unfiltered water before reaching the distribution tube.
Patent PT-2382970-E (PT)
Title: Stable pharmaceutical compositions containing 7-substituted-3,5-dihydroxyheptanoic acids or 7-substituted-3,5-dihydroxyheptenoic acids
Inventor: FOX MICHAEL
IPC: A61K9/14
Filed: 2001-04-09
Abstract: Pharmaceutical compositions that have excellent storage even though they include an active component that is susceptible to degradation in an acidic environment are disclosed. The stabilized pharmaceutical composition of the invention includes a ring-opened 7-substituted-,35-dihydroxyheptanoic or a ring opened 7-substituted-3,5-dihydroxyheptenoic acid, or a pharmaceutically acceptable salt thereof, as an component and a stabilizing effective amount of at least one amino-group containing polymeric compound or at least one amino-group containing polymeric compound, or combination thereof; wherein the stabilized pharmaceutical composition does not contain a stabilizing effective amount of another stabilizer of a combination of other stabilizers. The pharmaceutical composition may optionally include one or more pharmaceutically acceptable excipients such as a filler, a disintegrating agent and one or more lubricants such as magnesium stearate to aid compression where a tablet dosage form is desired.